About Careers MedBlog Contact us

Molecular Target for Alzheimer's Treatment Unveiled

by VR Sreeraman on November 7, 2008 at 1:54 PM
Font : A-A+

 Molecular Target for Alzheimer's Treatment Unveiled

A team of researchers has shown that a molecule called Cyclophilin D (CypD) interacts with amyloid beta (AB) peptide, the main constituent of plaques in the brains of Alzheimer's patients, within the mitochondria.

The study involving a transgenic mouse model of Alzheimer's disease suggests that blocking CypD and development of surrounding mitochondrial targets may be viable therapeutic strategies for the prevention and treatment of Alzheimer's disease, reports Nature.


Study leader Shi Du Yan, professor of clinical pathology in the Department's of Pathology and Surgery and in the Taub Institute for Research on Alzheimer's Disease and the Aging Brain at Columbia University Medical Center, says that this work describes how this mitochondrial process may be linked to synaptic failure in Alzheimer's disease.

During the study, Dr. Yan and colleagues observed that the cortical mitochondria isolated from Alzheimer's disease mice lacking CypD were resistant to AB- and Ca2+-induced mitochondria swelling and permeability transition, increased calcium buffering capacity, and attenuate generation of mitochondrial ROS.

Also, they found that CypD-deficient neurons protect against AB- and oxidative stress-induced cell death.

Importantly, they researchers found that deficiency of CycD greatly improved the learning, memory, and synaptic function of an Alzheimer's disease mouse model and alleviated AB-mediated reduction of long-term potentiation (LTP).

Thus, the CypD/AB-mediated mitochondrial permeability transition pore directly links to the cellular and synaptic perturbation relevant to the pathogenesis of Alzheimer's disease.

The study is published in the Sept. 21 on-line edition of Nature Medicine.

Source: ANI


Recommended Reading

Latest Mental Health News

Can Living in Deprived Areas and Depression Cause Premature Aging?
Disadvantaged urban areas and depression symptoms associated with premature aging.
The Aftermath of Gun Violence: Inadequate Mental Health Care for Injured Kids
There is an urgent need for mental health care in injured children after firearm injuries.
Shattering the Stigma: Evolving Landscape of Mental Health Support in the Workplace
Recently, a noteworthy transformation has occurred, with 81 percent of workplaces now placing increased emphasis on employee mental health.
Paradox of Intelligence and Thinking Speed
Individuals with higher intelligence scores demonstrated faster thinking exclusively in simple tasks, while they encountered longer solving times for complex problems.
Sleep Apnea Associated With Smaller Brain Volume, Study Finds
Individuals who have abnormal protein deposits in their brains and also experience more severe sleep apnea are more likely to have smaller volumes in a specific area of the brain.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Molecular Target for Alzheimer's Treatment Unveiled Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests